U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 44

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr4:1807549
GRCh38:
Chr4:1805822
FGFR3P461L, P573L, P574L, P575LAchondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Thanatophoric dysplasia, type 2,
Malignant tumor of urinary bladder, Germ cell tumor of testis, Cancer of cervix,
Muenke syndrome, Hypochondroplasia, Crouzon syndrome-acanthosis nigricans syndrome,
Levy-Hollister syndrome, Thanatophoric dysplasia type 1Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Colorectal cancer, Epidermal nevus, not provided,
...see more
Uncertain significance
(Dec 15, 2021)
criteria provided, multiple submitters, no conflicts
2.
GRCh37:
Chr4:1801055
GRCh38:
Chr4:1799328
FGFR3P62SFGFR3-related disoder, Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Thanatophoric dysplasia, type 2, Malignant tumor of urinary bladder, Germ cell tumor of testis,
Cancer of cervix, Muenke syndrome, Hypochondroplasia,
Crouzon syndrome-acanthosis nigricans syndrome, Levy-Hollister syndromeThanatophoric dysplasia type 1,
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Colorectal cancer, Epidermal nevus,
...see more
Uncertain significance
(Feb 1, 2022)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr4:1807915
GRCh38:
Chr4:1806188
FGFR3Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Thanatophoric dysplasia, type 2,
Malignant tumor of urinary bladder, Germ cell tumor of testis, Cancer of cervix,
Muenke syndrome, Hypochondroplasia, Crouzon syndrome-acanthosis nigricans syndrome,
Levy-Hollister syndrome, Thanatophoric dysplasia type 1Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Colorectal cancer, Epidermal nevus, not provided,
...see more
Benign/Likely benign
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr4:1807887
GRCh38:
Chr4:1806160
FGFR3K537R, K649R, K650R, K651RAchondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Thanatophoric dysplasia, type 2,
Malignant tumor of urinary bladder, Germ cell tumor of testis, Cancer of cervix,
Muenke syndrome, Hypochondroplasia, Crouzon syndrome-acanthosis nigricans syndrome,
Levy-Hollister syndrome, Thanatophoric dysplasia type 1Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Colorectal cancer, Epidermal nevus, not provided,
...see more
Uncertain significance
(Jan 17, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr4:1807658
GRCh38:
Chr4:1805931
FGFR3Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Thanatophoric dysplasia, type 2,
Malignant tumor of urinary bladder, Germ cell tumor of testis, Cancer of cervix,
Muenke syndrome, Hypochondroplasia, Crouzon syndrome-acanthosis nigricans syndrome,
Levy-Hollister syndrome, Thanatophoric dysplasia type 1Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Colorectal cancer, Epidermal nevus, Connective tissue disorder,
not provided, ...see more
Conflicting interpretations of pathogenicity
(Apr 14, 2022)
criteria provided, conflicting interpretations
6.
GRCh37:
Chr4:1806551
GRCh38:
Chr4:1804824
FGFR3V311L, V423L, V424L, V425LAchondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Thanatophoric dysplasia, type 2,
Malignant tumor of urinary bladder, Germ cell tumor of testis, Cancer of cervix,
Muenke syndrome, Hypochondroplasia, Crouzon syndrome-acanthosis nigricans syndrome,
Levy-Hollister syndrome, Thanatophoric dysplasia type 1Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Colorectal cancer, Epidermal nevus, Inborn genetic diseases,
not provided, ...see more
Uncertain significance
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr4:1806164
GRCh38:
Chr4:1804437
FGFR3L395I, L397IAchondroplasiaLikely pathogenic
(May 9, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr4:1806125
GRCh38:
Chr4:1804398
FGFR3G382S, G384SAchondroplasiaLikely pathogeniccriteria provided, single submitter
9.
FBN1AchondroplasiaLikely pathogeniccriteria provided, single submitter
10.
GRCh37:
Chr4:1807906
GRCh38:
Chr4:1806179
FGFR3AchondroplasiaUncertain significance
(Nov 3, 2021)
criteria provided, single submitter
11.
GRCh37:
Chr4:1807298
GRCh38:
Chr4:1805571
FGFR3D404G, D516G, D517G, D518GAchondroplasia, Epidermal nevus, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Cancer of cervix, Crouzon syndrome-acanthosis nigricans syndrome, Thanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Germ cell tumor of testis, Colorectal cancer,
Malignant tumor of urinary bladder, Levy-Hollister syndromeMuenke syndrome,
Hypochondroplasia, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, not provided,
...see more
Uncertain significance
(Jan 5, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr4:1806236
GRCh38:
Chr4:1804509
FGFR3L419F, L421FCrouzon syndrome-acanthosis nigricans syndrome, Hypochondroplasia, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Colorectal cancer, Muenke syndrome, Malignant tumor of urinary bladder,
Cancer of cervix, Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Germ cell tumor of testis, Levy-Hollister syndromeThanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Epidermal nevus, not provided,
...see more
Uncertain significance
(Jul 20, 2021)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr4:1807357
GRCh38:
Chr4:1805630
FGFR3K424E, K536E, K537E, K538EAchondroplasiaUncertain significance
(Nov 29, 2019)
criteria provided, single submitter
14.
GRCh37:
Chr4:1805477
GRCh38:
Chr4:1803750
FGFR3T330Inot provided, AchondroplasiaUncertain significance
(Sep 20, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr15:48812873
GRCh38:
Chr15:48520676
LOC113939944, FBN1C377YFamilial thoracic aortic aneurysm and aortic dissection, Marfan syndrome, Achondroplasia,
Marfan syndrome
Likely pathogenic
(Aug 24, 2021)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr4:1808981
GRCh38:
Chr4:1807254
FGFR3A782V, R807W, R693W, R805W, R806WHypochondroplasia, Epidermal nevus, Achondroplasia,
Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Cancer of cervix, Levy-Hollister syndrome, Muenke syndrome,
Malignant tumor of urinary bladder, Severe achondroplasia-developmental delay-acanthosis nigricans syndromeCrouzon syndrome-acanthosis nigricans syndrome,
Germ cell tumor of testis, Colorectal cancer, not provided,
...see more
Uncertain significance
(Oct 28, 2021)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr4:1806615
GRCh38:
Chr4:1804888
FGFR3S444F, S446F, S332F, S445FInborn genetic diseasesUncertain significance
(Jan 29, 2021)
criteria provided, single submitter
18.
GRCh37:
Chr4:1801071
GRCh38:
Chr4:1799344
FGFR3G67Dnot provided, Achondroplasia, Cancer of cervix,
Crouzon syndrome-acanthosis nigricans syndrome, Muenke syndrome, Epidermal nevus,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Levy-Hollister syndrome, Malignant tumor of urinary bladder,
Hypochondroplasia, Thanatophoric dysplasia type 1Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Malignant tumor of testis, Thanatophoric dysplasia, type 2, Carcinoma of colon,
...see more
Conflicting interpretations of pathogenicity
(May 7, 2022)
criteria provided, conflicting interpretations
19.
GRCh37:
Chr4:1808395
GRCh38:
Chr4:1806668
FGFR3N718S, N720S, N719S, N606SInborn genetic diseases, Crouzon syndrome-acanthosis nigricans syndrome, Malignant tumor of urinary bladder,
Carcinoma of colon, Cancer of cervix, Levy-Hollister syndrome,
Achondroplasia, Epidermal nevus, Malignant tumor of testis,
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Camptodactyly-tall stature-scoliosis-hearing loss syndromeMuenke syndrome,
Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2, Hypochondroplasia,
not provided, ...see more
Uncertain significance
(Jul 9, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr4:1808017
GRCh38:
Chr4:1806290
FGFR3A667S, A665S, A553S, A666SAchondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Cancer of cervix,
Hypochondroplasia, Epidermal nevus, Carcinoma of colon,
Crouzon syndrome-acanthosis nigricans syndrome, Levy-Hollister syndrome, Muenke syndrome,
Malignant tumor of urinary bladder, Severe achondroplasia-developmental delay-acanthosis nigricans syndromeMalignant tumor of testis,
Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2, not provided,
...see more
Uncertain significance
(Jul 22, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr4:1807977
GRCh38:
Chr4:1806250
FGFR3Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Cancer of cervix,
Hypochondroplasia, Epidermal nevus, Germ cell tumor of testis,
Crouzon syndrome-acanthosis nigricans syndrome, Levy-Hollister syndrome, Muenke syndrome,
Malignant tumor of urinary bladder, Severe achondroplasia-developmental delay-acanthosis nigricans syndromeColorectal cancer,
Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2, not provided,
...see more
Benign/Likely benign
(Feb 15, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr4:1807371
Chr4:1807123
GRCh38:
Chr4:1805644
Chr4:1805396
FGFR3, FGFR3N540K, N542K, N428K, N541K, Q485R, Q487R, Q373R, Q486RThanatophoric dysplasia type 1Pathogenic
(Jun 1, 2009)
no assertion criteria provided
23.
GRCh37:
Chr4:1806119
Chr4:1806111
GRCh38:
Chr4:1804392
Chr4:1804384
FGFR3, FGFR3G380R, G382R, L377R, L379RAchondroplasiaPathogenic
(Feb 1, 2006)
no assertion criteria provided
24.
GRCh37:
Chr4:1801143
GRCh38:
Chr4:1799416
FGFR3P91Lnot specified, not provided, Achondroplasia
Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
25.
GRCh37:
Chr4:1803341
GRCh38:
Chr4:1801614
FGFR3Achondroplasia, not specified, not provided
Conflicting interpretations of pathogenicity
(Oct 23, 2022)
criteria provided, conflicting interpretations
26.
GRCh37:
Chr4:1801219
GRCh38:
Chr4:1799492
FGFR3Levy-Hollister syndrome, Malignant tumor of urinary bladder, Epidermal nevus,
Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Crouzon syndrome-acanthosis nigricans syndrome, Germ cell tumor of testis, Muenke syndrome,
Colorectal cancer, Cancer of cervixThanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Hypochondroplasia, not provided,
not specified, Connective tissue disorder, ...see more
Benign/Likely benign
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr4:1806131
GRCh38:
Chr4:1804404
FGFR3F384L, F386LCrouzon syndrome-acanthosis nigricans syndrome, Levy-Hollister syndrome, Hypochondroplasia,
Achondroplasia, Cancer of cervix, Muenke syndrome,
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Colorectal cancer, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2Epidermal nevus,
Germ cell tumor of testis, Malignant tumor of urinary bladder, Connective tissue disorder,
not specified, not provided, Hypochondroplasia,
...see more
Benign/Likely benign
(Dec 1, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr4:1807876
GRCh38:
Chr4:1806149
FGFR3Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Levy-Hollister syndrome, Hypochondroplasia,
Achondroplasia, Cancer of cervix, Muenke syndrome,
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Colorectal cancer, Crouzon syndrome-acanthosis nigricans syndrome,
Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2Epidermal nevus,
Germ cell tumor of testis, Malignant tumor of urinary bladder, not provided,
...see more
Benign/Likely benign
(Aug 8, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr4:1807890
GRCh38:
Chr4:1806163
FGFR3K650T, K652T, K538T, K651Tnot provided, Achondroplasia, Epidermal nevus,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Cancer of cervix, Thanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Malignant tumor of urinary bladder, Crouzon syndrome-acanthosis nigricans syndrome,
Levy-Hollister syndrome, Muenke syndromeHypochondroplasia,
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Malignant tumor of testis, Carcinoma of colon,
FGFR3-related disorder, ...see more
Pathogenic
(Oct 2, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr4:1808988
GRCh38:
Chr4:1807261
FGFR3not provided, Achondroplasia, Epidermal nevus,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Cancer of cervix, Thanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Malignant tumor of urinary bladder, Crouzon syndrome-acanthosis nigricans syndrome,
Levy-Hollister syndrome, Muenke syndromeColorectal cancer,
Germ cell tumor of testis, Hypochondroplasia, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
...see more
Pathogenic
(Aug 8, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr4:1801122
GRCh38:
Chr4:1799395
FGFR3S84LHypochondroplasia, Thanatophoric dysplasia, type 2, Thanatophoric dysplasia type 1,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Crouzon syndrome-acanthosis nigricans syndrome,
Achondroplasia, Muenke syndrome, Levy-Hollister syndrome,
not provided, Achondroplasia ...see more
Pathogenic/Likely pathogenic
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr4:1803657
GRCh38:
Chr4:1801930
FGFR3S279Cnot provided, AchondroplasiaPathogenic/Likely pathogenic
(Jun 13, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr4:1807370
GRCh38:
Chr4:1805643
FGFR3N540S, N542S, N541S, N428SInborn genetic diseases, not provided, Hypochondroplasia,
Achondroplasia, Neurodevelopmental delay
Conflicting interpretations of pathogenicity
(Feb 23, 2023)
criteria provided, conflicting interpretations
34.
GRCh37:
Chr4:1807891
GRCh38:
Chr4:1806164
FGFR3K650N, K652N, K651N, K538NAchondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Thanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Crouzon syndrome-acanthosis nigricans syndrome, Germ cell tumor of testis,
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Epidermal nevus, Malignant tumor of urinary bladder,
Muenke syndrome, Cancer of cervixColorectal cancer,
Levy-Hollister syndrome, Hypochondroplasia, not provided,
Hypochondroplasia, ...see more
Pathogenic/Likely pathogenic
(Mar 17, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr4:1807890
GRCh38:
Chr4:1806163
FGFR3K650M, K652M, K538M, K651MAchondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Thanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Crouzon syndrome-acanthosis nigricans syndrome, Germ cell tumor of testis,
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Epidermal nevus, Malignant tumor of urinary bladder,
Muenke syndrome, Cancer of cervixColorectal cancer,
Levy-Hollister syndrome, Hypochondroplasia, not provided,
Hypochondroplasia, ...see more
Pathogenic
(Sep 29, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr4:1803571
GRCh38:
Chr4:1801844
FGFR3P250RInborn genetic diseases, Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2, Crouzon syndrome-acanthosis nigricans syndrome,
Germ cell tumor of testis, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Epidermal nevus,
Malignant tumor of urinary bladder, Muenke syndromeCancer of cervix,
Colorectal cancer, Levy-Hollister syndrome, Hypochondroplasia,
FGFR3-related chondrodysplasia, Crouzon syndrome, Coronal craniosynostosis,
Generalized non-motor (absence) seizure, Seizure, Infantile axial hypotonia,
Unilateral renal agenesis, Facial asymmetry, Craniosynostosis syndrome,
not provided, Hypochondroplasia, Muenke syndrome,
Achondroplasia, Abnormality of the nervous system, ...see more
Pathogenic/Likely pathogenic
(Dec 28, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr4:1803568
GRCh38:
Chr4:1801841
FGFR3S249CConnective tissue disorder, Achondroplasia, Carcinoma of colon,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2,
Crouzon syndrome-acanthosis nigricans syndrome, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Malignant tumor of testis,
Epidermal nevus, Malignant tumor of urinary bladderMuenke syndrome,
Cancer of cervix, Levy-Hollister syndrome, Hypochondroplasia,
not provided, Cancer of cervix, Malignant tumor of urinary bladder,
Thanatophoric dysplasia type 1, ...see more
Pathogenic
(Feb 23, 2023)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr4:1807371
GRCh38:
Chr4:1805644
FGFR3N540K, N542K, N541K, N428KConnective tissue disorder, Achondroplasia, Carcinoma of colon,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2,
Crouzon syndrome-acanthosis nigricans syndrome, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Malignant tumor of testis,
Epidermal nevus, Malignant tumor of urinary bladderMuenke syndrome,
Cancer of cervix, Levy-Hollister syndrome, Hypochondroplasia,
Inborn genetic diseases, not provided, Larsen syndrome,
Hypochondroplasia, Achondroplasia, Short stature,
...see more
Pathogenic/Likely pathogenic
(Oct 14, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr4:1807371
GRCh38:
Chr4:1805644
FGFR3N540K, N542K, N428K, N541Knot provided, Hypochondroplasia, Achondroplasia,
Neurodevelopmental delay
Pathogenic
(Feb 23, 2023)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr4:1808987
GRCh38:
Chr4:1807260
FGFR3V784EAchondroplasia, Colorectal cancer, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Hypochondroplasia, Malignant tumor of urinary bladder, Crouzon syndrome-acanthosis nigricans syndrome,
Germ cell tumor of testis, Epidermal nevus, Muenke syndrome,
Cancer of cervix, Thanatophoric dysplasia type 1Thanatophoric dysplasia, type 2,
Levy-Hollister syndrome, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, not provided,
...see more
Pathogenic
(Sep 12, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr4:1803564
GRCh38:
Chr4:1801837
FGFR3R248CFGFR3-related disorder, Connective tissue disorder, FGFR3-related chondrodysplasia,
Achondroplasia, Carcinoma of colon, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2, Crouzon syndrome-acanthosis nigricans syndrome,
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Malignant tumor of testisEpidermal nevus,
Malignant tumor of urinary bladder, Muenke syndrome, Cancer of cervix,
Levy-Hollister syndrome, Hypochondroplasia, not provided,
Cancer of cervix, Thanatophoric dysplasia type 1, Achondroplasia,
Hamartoma, Skeletal dysplasia, Growth delay,
Bowed humerus, Bell-shaped thorax, Small for gestational age,
Short stature, Disproportionate short-limb short stature, Lethal short-limbed short stature,
Femoral bowing, Short ribs, Narrow chest,
Lower limb undergrowth, Upper limb undergrowth, ...see more
Pathogenic
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr4:1806104
GRCh38:
Chr4:1804377
FGFR3G375C, G377Cnot providedPathogenic
(Feb 24, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr4:1806119
GRCh38:
Chr4:1804392
FGFR3G380R, G382Rnot provided, Hypochondroplasia, Achondroplasia
Pathogenic
(Dec 15, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr4:1806119
GRCh38:
Chr4:1804392
FGFR3G380R, G382RConnective tissue disorder, Inborn genetic diseases, Achondroplasia,
Carcinoma of colon, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Thanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Crouzon syndrome-acanthosis nigricans syndrome, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Malignant tumor of testis, Epidermal nevusMalignant tumor of urinary bladder,
Muenke syndrome, Cancer of cervix, Levy-Hollister syndrome,
Hypochondroplasia, not specified, not provided,
Thanatophoric dysplasia type 1, Hypochondroplasia, Achondroplasia,
...see more
Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
Format
Items per page
Sort by
Choose Destination